REPORT ID 4927

Global Anti-malarial Drugs Market Research Report 2017

Publish Date
20-Dec-17
Pages
108
Format
Electronic (PDF)

In this report, the global Anti-malarial Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Anti-malarial Drugs in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Anti-malarial Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Merck KGaA
    F. Hoffmann-La Roche AG
    Novartis AG
    GlaxoSmithKline Plc
    Ranbaxy Laboratories
    Zydus Cadila
    Alvizia Health Care
    Bayer AG
    Pfizer, Inc.
    Ipca Laboratories Ltd
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Quinine
    Chloroquine
    Pyrimethamine
    Amodiaquine
    Proguanil
    Mefloquine
    Sulfonamide
    Other
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Falciparum Malaria
    Vivax Malaria
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Anti-malarial Drugs Market Research Report 2017
1 Anti-malarial Drugs Market Overview
    1.1 Product Overview and Scope of Anti-malarial Drugs
    1.2 Anti-malarial Drugs Segment by Type (Product Category)
        1.2.1 Global Anti-malarial Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Anti-malarial Drugs Production Market Share by Type (Product Category) in 2016
        1.2.3 Quinine
        1.2.4 Chloroquine
        1.2.5 Pyrimethamine
        1.2.6 Amodiaquine
        1.2.7 Proguanil
        1.2.8 Mefloquine
        1.2.9 Sulfonamide
        1.2.10 Other
    1.3 Global Anti-malarial Drugs Segment by Application
        1.3.1 Anti-malarial Drugs Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Falciparum Malaria
        1.3.3 Vivax Malaria
        1.3.4 Others
    1.4 Global Anti-malarial Drugs Market by Region (2012-2022)
        1.4.1 Global Anti-malarial Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Anti-malarial Drugs (2012-2022)
        1.5.1 Global Anti-malarial Drugs Revenue Status and Outlook (2012-2022)
        1.5.2 Global Anti-malarial Drugs Capacity, Production Status and Outlook (2012-2022)

2 Global Anti-malarial Drugs Market Competition by Manufacturers
    2.1 Global Anti-malarial Drugs Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Anti-malarial Drugs Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Anti-malarial Drugs Production and Share by Manufacturers (2012-2017)
    2.2 Global Anti-malarial Drugs Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Anti-malarial Drugs Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Anti-malarial Drugs Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Anti-malarial Drugs Market Competitive Situation and Trends
        2.5.1 Anti-malarial Drugs Market Concentration Rate
        2.5.2 Anti-malarial Drugs Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Anti-malarial Drugs Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Anti-malarial Drugs Capacity and Market Share by Region (2012-2017)
    3.2 Global Anti-malarial Drugs Production and Market Share by Region (2012-2017)
    3.3 Global Anti-malarial Drugs Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Anti-malarial Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Anti-malarial Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Anti-malarial Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Anti-malarial Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Anti-malarial Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Anti-malarial Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Anti-malarial Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Anti-malarial Drugs Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Anti-malarial Drugs Consumption by Region (2012-2017)
    4.2 North America Anti-malarial Drugs Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Anti-malarial Drugs Production, Consumption, Export, Import (2012-2017)
    4.4 China Anti-malarial Drugs Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Anti-malarial Drugs Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Anti-malarial Drugs Production, Consumption, Export, Import (2012-2017)
    4.7 India Anti-malarial Drugs Production, Consumption, Export, Import (2012-2017)

5 Global Anti-malarial Drugs Production, Revenue (Value), Price Trend by Type
    5.1 Global Anti-malarial Drugs Production and Market Share by Type (2012-2017)
    5.2 Global Anti-malarial Drugs Revenue and Market Share by Type (2012-2017)
    5.3 Global Anti-malarial Drugs Price by Type (2012-2017)
    5.4 Global Anti-malarial Drugs Production Growth by Type (2012-2017)

6 Global Anti-malarial Drugs Market Analysis by Application
    6.1 Global Anti-malarial Drugs Consumption and Market Share by Application (2012-2017)
    6.2 Global Anti-malarial Drugs Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Anti-malarial Drugs Manufacturers Profiles/Analysis
    7.1 Merck KGaA
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Anti-malarial Drugs Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Merck KGaA Anti-malarial Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 F. Hoffmann-La Roche AG
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Anti-malarial Drugs Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 F. Hoffmann-La Roche AG Anti-malarial Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Novartis AG
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Anti-malarial Drugs Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Novartis AG Anti-malarial Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 GlaxoSmithKline Plc
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Anti-malarial Drugs Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 GlaxoSmithKline Plc Anti-malarial Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Ranbaxy Laboratories
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Anti-malarial Drugs Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Ranbaxy Laboratories Anti-malarial Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Zydus Cadila
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Anti-malarial Drugs Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Zydus Cadila Anti-malarial Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Alvizia Health Care
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Anti-malarial Drugs Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Alvizia Health Care Anti-malarial Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Bayer AG
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Anti-malarial Drugs Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Bayer AG Anti-malarial Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Pfizer, Inc.
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Anti-malarial Drugs Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Pfizer, Inc. Anti-malarial Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Ipca Laboratories Ltd
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Anti-malarial Drugs Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Ipca Laboratories Ltd Anti-malarial Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview

8 Anti-malarial Drugs Manufacturing Cost Analysis
    8.1 Anti-malarial Drugs Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Anti-malarial Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Anti-malarial Drugs Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Anti-malarial Drugs Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Anti-malarial Drugs Market Forecast (2017-2022)
    12.1 Global Anti-malarial Drugs Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Anti-malarial Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Anti-malarial Drugs Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Anti-malarial Drugs Price and Trend Forecast (2017-2022)
    12.2 Global Anti-malarial Drugs Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Anti-malarial Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Anti-malarial Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Anti-malarial Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Anti-malarial Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Anti-malarial Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Anti-malarial Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Anti-malarial Drugs Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Anti-malarial Drugs Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer